Fact CheckerSign in

NCT04024631Recruiting

Phenotyping Genetic Risk for Type 2 Diabetes

Phenotyping Children and Adults With Possible High or Low Genetic Risk for Type 2 Diabetes

Source: ClinicalTrials.gov · Last updated 21 Sept 2026

Brief summary (registry, in English)

This study tests the hypothesis that non-diabetic individuals with a high genetic risk score for type 2 diabetes have impaired glucose tolerance and insulin resistance compared to those with a low genetic risk score for type 2 diabetes.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
100 (estimated)
First submitted
13 Jul 2019
Start date
17 Jun 2019
Primary completion date
30 Jun 2027
Lead sponsor
University of Pennsylvania
NCT number
NCT04024631

What you commit to

  • Study type: Interventional
  • Planned participants: 100
  • From 17 Jun 2019 to the primary completion date, 30 Jun 2027
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • prior diagnosis of type 1, type 2, or secondary diabetes
  • recent systemic chemotherapy use

Other illness

  • hypothalamic obesity or related genetic disorder of metabolism
  • gastrointestinal impairment or surgery that may impact absorption
  • major organ system illness or any underlying condition requiring regular medication or treatment that could make implementation of the protocol or interpretation of the study results difficult

Lab values

  • use of medications that would impact glucose and insulin response such as steroids, metformin or other anti-diabetic medication
  • acute illness that may impact insulin and glucose dynamics

Other

  • pregnancy
  • anemia
  • inability to comply with study protocol

Who the study is looking for

  • Age 10-70 years
  • Prior participant of the UPenn Biobank or Center for Applied Genomics Biobank and agreed to be recontacted for future research.
  • Adults with BMI 25kg/m2 or higher, children and adolescents with BMI 85th percentile or higher

Age in the registry: 10 years to 70 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Pennsylvania
Coordinator of this site? Confirm its status
PhiladelphiaUnited StatesRecruiting
Childrens Hospital of Philadelphia
Coordinator of this site? Confirm its status
PhiladelphiaUnited StatesNot yet recruiting

This page is information, not medical advice. Discuss any trial with your doctor.